{"id":1068200,"date":"2022-04-13T01:50:14","date_gmt":"2022-04-13T05:50:14","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/medicinova-announces-completion-of-enrollment-in-the-phase-2-clinical-trial-of-mn-166-ibudilast-in-hospitalized-covid-19-patients-at-risk-for-acute\/"},"modified":"2024-08-18T11:44:12","modified_gmt":"2024-08-18T15:44:12","slug":"medicinova-announces-completion-of-enrollment-in-the-phase-2-clinical-trial-of-mn-166-ibudilast-in-hospitalized-covid-19-patients-at-risk-for-acute","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/medicinova-announces-completion-of-enrollment-in-the-phase-2-clinical-trial-of-mn-166-ibudilast-in-hospitalized-covid-19-patients-at-risk-for-acute.php","title":{"rendered":"MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial of MN-166 (ibudilast) in Hospitalized COVID-19 Patients at Risk for Acute&#8230;"},"content":{"rendered":"<p><![CDATA[LA JOLLA, Calif., April  12, 2022  (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that the Phase 2 clinical trial of MN-166 (ibudilast) in hospitalized COVID-19 patients at risk for developing acute respiratory distress syndrome (ARDS) has completed enrollment.]]><\/p>\n<p>Read the original:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/04\/13\/2421520\/0\/en\/MediciNova-Announces-Completion-of-Enrollment-in-the-Phase-2-Clinical-Trial-of-MN-166-ibudilast-in-Hospitalized-COVID-19-Patients-at-Risk-for-Acute-Respiratory-Distress-Syndrome.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial of MN-166 (ibudilast) in Hospitalized COVID-19 Patients at Risk for Acute...\">MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial of MN-166 (ibudilast) in Hospitalized COVID-19 Patients at Risk for Acute...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the original: MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial of MN-166 (ibudilast) in Hospitalized COVID-19 Patients at Risk for Acute... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/medicinova-announces-completion-of-enrollment-in-the-phase-2-clinical-trial-of-mn-166-ibudilast-in-hospitalized-covid-19-patients-at-risk-for-acute.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068200","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068200"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068200"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068200\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068200"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068200"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}